Literature DB >> 17850337

Phylogenetic concordance analysis shows an emerging pathogen is novel and endemic.

Andrew Storfer1, Michael E Alfaro, Benjamin J Ridenhour, James K Jancovich, Stephen G Mech, Matthew J Parris, James P Collins.   

Abstract

Distinguishing whether pathogens are novel or endemic is critical for controlling emerging infectious diseases, an increasing threat to wildlife and human health. To test the endemic vs. novel pathogen hypothesis, we present a unique analysis of intraspecific host-pathogen phylogenetic concordance of tiger salamanders and an emerging Ranavirus throughout Western North America. There is significant non-concordance of host and virus gene trees, suggesting pathogen novelty. However, non-concordance has likely resulted from virus introductions by human movement of infected salamanders. When human-associated viral introductions are excluded, host and virus gene trees are identical, strongly supporting coevolution and endemism. A laboratory experiment showed an introduced virus strain is significantly more virulent than endemic strains, likely due to artificial selection for high virulence. Thus, our analysis of intraspecific phylogenetic concordance revealed that human introduction of viruses is the mechanism underlying tree non-concordance and possibly disease emergence via artificial selection.

Entities:  

Mesh:

Year:  2007        PMID: 17850337     DOI: 10.1111/j.1461-0248.2007.01102.x

Source DB:  PubMed          Journal:  Ecol Lett        ISSN: 1461-023X            Impact factor:   9.492


  16 in total

1.  The genome sequence of the emerging common midwife toad virus identifies an evolutionary intermediate within ranaviruses.

Authors:  Carla Mavian; Alberto López-Bueno; Ana Balseiro; Rosa Casais; Antonio Alcamí; Alí Alejo
Journal:  J Virol       Date:  2012-02-01       Impact factor: 5.103

2.  Mortality rates differ among amphibian populations exposed to three strains of a lethal ranavirus.

Authors:  Danna M Schock; Trent K Bollinger; James P Collins
Journal:  Ecohealth       Date:  2010-02-09       Impact factor: 3.184

3.  Pathogen host switching in commercial trade with management recommendations.

Authors:  Angela M Picco; Abraham P Karam; James P Collins
Journal:  Ecohealth       Date:  2010-04-22       Impact factor: 3.184

4.  Combined effects of virus, pesticide, and predator cue on the larval tiger salamander (Ambystoma tigrinum).

Authors:  Jacob L Kerby; Alison J Hart; Andrew Storfer
Journal:  Ecohealth       Date:  2011-04-27       Impact factor: 3.184

5.  Introduction of ranavirus to isolated wood frog populations could cause local extinction.

Authors:  Julia E Earl; Matthew J Gray
Journal:  Ecohealth       Date:  2014-06-25       Impact factor: 3.184

6.  Ranavirus could facilitate local extinction of rare amphibian species.

Authors:  Julia E Earl; Jordan C Chaney; William B Sutton; Carson E Lillard; Andrew J Kouba; Cecilia Langhorne; Jessi Krebs; Rebecca P Wilkes; Rachel D Hill; Debra L Miller; Matthew J Gray
Journal:  Oecologia       Date:  2016-06-25       Impact factor: 3.225

7.  Combined effects of atrazine and chlorpyrifos on susceptibility of the tiger salamander to Ambystoma tigrinum virus.

Authors:  Jacob L Kerby; Andrew Storfer
Journal:  Ecohealth       Date:  2009-05-05       Impact factor: 3.184

Review 8.  Ecopathology of ranaviruses infecting amphibians.

Authors:  Debra Miller; Matthew Gray; Andrew Storfer
Journal:  Viruses       Date:  2011-11-22       Impact factor: 5.818

9.  Transcriptional response of Mexican axolotls to Ambystoma tigrinum virus (ATV) infection.

Authors:  Jennifer D Cotter; Andrew Storfer; Robert B Page; Christopher K Beachy; S Randal Voss
Journal:  BMC Genomics       Date:  2008-10-20       Impact factor: 3.969

10.  Ranavirus infections associated with skin lesions in lizards.

Authors:  Anke C Stöhr; Silvia Blahak; Kim O Heckers; Jutta Wiechert; Helge Behncke; Karina Mathes; Pascale Günther; Peer Zwart; Inna Ball; Birgit Rüschoff; Rachel E Marschang
Journal:  Vet Res       Date:  2013-09-27       Impact factor: 3.683

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.